Scleritis

13 registered clinical trials studyying Scleritis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715	University of Siena	—
Unknown	Tofacitinib for Inflammatory Eye Disease NCT03580343	Washington University School of Medicine	Phase 2
Unknown	A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis NCT03465111	Metropolitan Eye Research & Surgery Institute	Phase 2
Terminated	LSFG-SKIN, Laser Speckle Flowgraphy NCT03660618	Randy Kardon	N/A
Completed	Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients NCT02764697	Tampa Bay Uveitis Center, LLC	Phase 4
Completed	Ocular Manifestations in Rheumatic Diseases NCT03753893	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	—
Completed	Gevokizumab for Active Scleritis NCT01835132	National Eye Institute (NEI)	Phase 1 / Phase 2
Unknown	Causes of Visual Loss in Retinal Disease NCT01613963	Royal Surrey County Hospital NHS Foundation Trust	—
Completed	Sirolimus Injections for Autoimmune Scleritis NCT01517074	National Eye Institute (NEI)	Phase 1 / Phase 2
Terminated	Human Samples and Data Repository NCT00539370	National Eye Institute (NEI)	—
Completed	Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation NCT00415506	Oregon Health and Science University	Phase 1 / Phase 2
Terminated	Study Evaluating PSI-697 in Patients With Scleritis NCT00367692	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 1
Completed	Infliximab to Treat Non-Infectious Scleritis NCT00075075	National Eye Institute (NEI)	Phase 1